Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

Current developments in transcatheter aortic valve implantation techniques.

M Thielmann1, P Kahlert, T Konorza

  • 1Department of Thoracic and Cardiovascular Surgery, West German Heart Center Essen, University Hospital Essen, Hufelandstr. 55, 45122, Essen, Germany. matthias.thielmann@uk-essen.de

Herz
|November 4, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis.

European heart journal·2022
Same author

[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"].

Der Anaesthesist·2020
Same author

Histidine metabolism after Bretschneider cardioplegia in cardiac surgical patients.

Physiological research·2018
Same author

Erratum to: Imaging for planning of transcatheter aortic valve implantation.

Herz·2017
Same author

Imaging for planning of transcatheter aortic valve implantation.

Herz·2017
Same author

Perfusion bioreactor-based cryopreservation of 3D human mesenchymal stromal cell tissue grafts.

Cryobiology·2017

Transcatheter aortic valve implantation (TAVI) is a key treatment for aortic stenosis. Ongoing advancements aim to improve TAVI devices, addressing limitations like leakage and complications for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Transcatheter aortic valve implantation (TAVI) is a primary treatment for high-risk symptomatic aortic stenosis patients.
  • Recent years show increased TAVI adoption due to device evolution, shifting treatment paradigms.
  • Initial TAVI devices had issues, but many have been refined for clinical use.

Purpose of the Study:

  • To review current advancements in transcatheter aortic valve implantation (TAVI) technology.
  • To highlight ongoing research and development in TAVI devices and procedures.
  • To discuss solutions for existing TAVI limitations and future directions.

Main Methods:

  • Review of current literature and technological developments in TAVI.

Related Experiment Videos

Last Updated: May 27, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

  • Analysis of limitations in existing TAVI systems.
  • Identification of key areas for future TAVI device innovation.

    • Main Results:

    • Current TAVI systems face challenges including valve design, paravalvular leakage, deployment issues, thromboembolic events, and complications.
    • Key development areas include device miniaturization, expanded valve sizing, retrievable/repositionable systems, improved stent design, advanced imaging, and thromboembolic prevention.

    Conclusions:

    • Despite progress, TAVI systems require further refinement to overcome persistent limitations.
    • Future TAVI development focuses on enhanced safety, efficacy, and broader applicability through technological innovation.
    • Continued research is crucial for optimizing TAVI as a treatment for aortic stenosis.